CoChat

A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH

Open access
Taylor‐Weiner, Amaro, Pokkalla, Harsha, Han, Ling, Jia, Catherine, Huss, Ryan, Chung, Chuhan, Elliott, Hunter, Glass, Benjamin, Pethia, Kishalve, Carrasco‐Zevallos, Oscar, Shukla, Chinmay, Khettry, Urmila, Najarian, Robert, Taliano, Ross, Subramanian, G. Mani, Myers, Robert P., Wapinski, Ilan, Khosla, Aditya, Resnick, Murray, Montalto, Michael C., Anstee, Quentin M., Wong, Vincent Wai‐Sun, Trauner, Michael, Lawitz, Eric J., Harrison, Stephen A., Okanoue, Takeshi, Romero‐Gomez, Manuel, Goodman, Zachary, Loomba, Rohit, Beck, Andrew H., Younossi, Zobair M. · 2021 · Hepatology
Cited by 195

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background and Aims: Manual histological assessment is currently the accepted standard for diagnosing and monitoring disease progression in NASH, but is limited by variability in interpretation and insensitivity to change. Thus, there is a critical need for improved tools to assess liver pathology in order to risk stratify NASH patients and monitor treatment response. Approach and Results: Here, we describe a machine learning (ML)‐based approach to liver histology assessment, which accurately characterizes disease severity and heterogeneity, and sensitively quantifies treatment response in NASH. We use samples from three randomized controlled trials to build and then validate deep convolutional neural networks to measure key histological features in NASH, including steatosis, inflammation, hepatocellular ballooning, and fibrosis. The ML‐based predictions showed strong correlations with expert pathologists and were prognostic of progression to cirrhosis and liver‐related clinical events. We developed a heterogeneity‐sensitive metric of fibrosis response, the Deep Learning Treatment Assessment Liver Fibrosis score, which measured antifibrotic treatment effects that went undetected by manual pathological staging and was concordant with histological disease progression. Conclusions: Our ML method has shown reproducibility and sensitivity and was prognostic for disease progression, demonstrating the power of ML to advance our understanding of disease heterogeneity in NASH, risk stratify affected patients, and facilitate the development of therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.31750

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 195

Metadata

Authors
Taylor‐Weiner, A., Pokkalla, H., Han, L., Jia, C., Huss, R., Chung, C., Elliott, H., Glass, B., Pethia, K., Carrasco‐Zevallos, O., Shukla, C., Khettry, U., Najarian, R., Taliano, R., Subramanian, G. M., Myers, R. P., Wapinski, I., Khosla, A., Resnick, M., Montalto, M. C., Anstee, Q. M., Wong, V. W., Trauner, M., Lawitz, E. J., Harrison, S. A., Okanoue, T., Romero‐Gomez, M., Goodman, Z., Loomba, R., Beck, A. H., & Younossi, Z. M.
Venue
Hepatology
Published
2021-06-24
Volume
74
Issue
1
Pages
133-147
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W3127206578
Cited by
195
References
7
FWCI
21.29
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH. https://app.cochat.ai/papers/10.1002/hep.31750
The paper
Taylor‐Weiner, A., Pokkalla, H., Han, L., Jia, C., Huss, R., Chung, C., Elliott, H., Glass, B., Pethia, K., Carrasco‐Zevallos, O., Shukla, C., Khettry, U., Najarian, R., Taliano, R., Subramanian, G. M., Myers, R. P., Wapinski, I., Khosla, A., Resnick, M., . . . Younossi, Z. M. (2021). A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH. Hepatology. https://doi.org/10.1002/hep.31750

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.